Ken Prendergast

Ken Prendergast has worked as a journalist for publications such as NEOtrans, Sun Newspapers, Ohio Passenger Rail News, Passenger Transport, and others. He also provided consulting services to transportation agencies, real estate firms, port authorities and nonprofit organizations. Writing about cities, transportation, history and the people who create these.

Lakewood reaches settlement with hospital site developer

According to a statement released today by the City of Lakewood, the city has reached a settlement agreement with Carnegie Management and Development Corp. of Westlake regarding the redevelopment of the former Lakewood Hospital site. The settlement resulted from the early termination of an agreement between the two parties before construction began.

Read More

Lakewood reaches settlement with hospital site developer Read More »

Why does Circle Square get love and nuCLEus doesn’t?

Two births were noted in 2014. Ideas for a pair of major urban core real estate developments in Cleveland — nuCLEus and Circle Square — were set into motion, leading to much excitement and debate by everyone from urbanistas to media to fellow developers to elected officials.

Since those births six years ago, neither project has turned a shovel of dirt for new construction. Yet nuCLEus gets publicly criticized and doubted while Circle Square doesn’t. Is that fair? Let’s take a look at that….

Read More

Why does Circle Square get love and nuCLEus doesn’t? Read More »

Biotech firm Abeona to expand Cleveland production facilities

A young, growing biotechnology company is expanding its presence again in Cleveland. Abeona Therapeutics LLC is adding to its production facilities by leasing and modifying 12,000 square feet at the MidTown Tech Park Building No. 1, 6700 Euclid Ave.

That brings the publicly traded company’s (Nasdaq: ABEO) Cleveland presence to 38,000 square feet. It currently has 65 employees in Cleveland — more than triple the employment the firm had here just three years ago. Abeona is a clinical stage company developing gene therapy and plasma-based therapies for severe and life-threatening rare genetic diseases.

Read More

Biotech firm Abeona to expand Cleveland production facilities Read More »

Sherwin-William HQ+R&D project restarts; development team announced

UPDATED WITH PRESS RELEASE INFO

Reports are coming out today that Sherwin-Williams (SHW) has restarted the development of its global headquarters plus research and development facilities (HQ+R&D). But the months-long pause has pushed back the project’s completion from 2023 to 2024. The reason is the global pandemic and the economic disruption that it is causing.

Read More

Sherwin-William HQ+R&D project restarts; development team announced Read More »

One-million-square-foot mixed-use project planned next to I-271

Cleveland-area real estate developer Cannata Companies is making a major play at a 14.5-acre site next to Interstate 271 in Warrensville Heights. Envisioned is a 1-million-square-foot, $87-million mixed-use development called SilverPoint.

According to a SilverPoint presentation, the Dodge Reports and information from a preliminary massing graphic, the development could have structures potentially rising from four to 11 stories high for apartments, hotel, offices and ground-floor retail/restaurants.

Read More

One-million-square-foot mixed-use project planned next to I-271 Read More »

Little Italy demolition OK’d, development plan tabled

It’s not Italy’s Leaning Tower of Pisa, but La Barberia University Spa, 12115 Mayfield Rd. in Cleveland’s Little Italy, has an obvious eastward lean to it. In fact, the only things keeping the 126-plus-year-old building from tipping into the Tavern of Little Italy next door are some support posts and an enclosure for an automated teller machine.

Read More

Little Italy demolition OK’d, development plan tabled Read More »